tirzepatide self injection Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity How & Where to Inject

We know that the transition to medications like Ozempic or Zepbound is a significant step, and we are here to support you with science, empathy, and transparency

At lower doses, people can eat more normally than at higher doses, but support is still valuable

Our expert medical team reviews your weight loss progress, facial anatomy, and goals to design a fully tailored plan

Because semaglutide provides a stronger, longer-lasting signal to receptors, it increases the likelihood of greater weight loss and faster improvements in metabolism

Semaglutide is a GLP-1 receptor agonist used primarily for treating type 2 diabetes and obesity by enhancing insulin secretion and reducing appetite

Although these symptoms often improve over time, they can still limit the therapys usefulness for some patients